1
|
Kostenkova K, Levina A, Walters DA, Murakami HA, Lay PA, Crans DC. Vanadium(V) Pyridine-Containing Schiff Base Catecholate Complexes are Lipophilic, Redox-Active and Selectively Cytotoxic in Glioblastoma (T98G) Cells. Chemistry 2023; 29:e202302271. [PMID: 37581946 DOI: 10.1002/chem.202302271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 08/05/2023] [Accepted: 08/08/2023] [Indexed: 08/17/2023]
Abstract
Two new series of complexes with pyridine-containing Schiff bases, [VV O(SALIEP)L] and [VV O(Cl-SALIEP)L] (SALIEP=N-(salicylideneaminato)-2-(2-aminoethylpyridine; Cl-SALIEP=N-(5-chlorosalicylideneaminato)-2-(2-aminoethyl)pyridine, L=catecholato(2-) ligand) have been synthesized. Characterization by 1 H and 51 V NMR and UV-Vis spectroscopies confirmed that: 1) most complexes form two major geometric isomers in solution, and [VV O(SALIEP)(DTB)] (DTB=3,5-di-tert-butylcatecholato(2-)) forms two isomers that equilibrate in solution; and 2) tert-butyl substituents were necessary to stabilize the reduced VIV species (EPR spectroscopy and cyclic voltammetry). The pyridine moiety within the Schiff base ligands significantly changed their chemical properties with unsubstituted catecholate ligands compared with the parent HSHED (N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine) Schiff base complexes. Immediate reduction to VIV occurred for the unsubstituted-catecholato VV complexes on dissolution in DMSO. By contrast, the pyridine moiety within the Schiff base significantly improved the hydrolytic stability of [VV O(SALIEP)(DTB)] compared with [VV O(HSHED)(DTB)]. [VV O(SALIEP)(DTB)] had moderate stability in cell culture media. There was significant cellular uptake of the intact complex by T98G (human glioblastoma) cells and very good anti-proliferative activity (IC50 6.7±0.9 μM, 72 h), which was approximately five times higher than for the non-cancerous human cell line, HFF-1 (IC50 34±10 μM). This made [VV O(SALIEP)(DTB)] a potential drug candidate for the treatment of advanced gliomas by intracranial injection.
Collapse
Affiliation(s)
- Kateryna Kostenkova
- Department of Chemistry and, The Cell and Molecular Biology Program, Colorado State University, 1301 Center Ave Chemistry B101 Campus Delivery 1872, Fort Collins, CO 80523-1872, USA
| | - Aviva Levina
- School of Chemistry and Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia
| | - Drew A Walters
- Department of Chemistry and, The Cell and Molecular Biology Program, Colorado State University, 1301 Center Ave Chemistry B101 Campus Delivery 1872, Fort Collins, CO 80523-1872, USA
| | - Heide A Murakami
- Department of Chemistry and, The Cell and Molecular Biology Program, Colorado State University, 1301 Center Ave Chemistry B101 Campus Delivery 1872, Fort Collins, CO 80523-1872, USA
| | - Peter A Lay
- School of Chemistry and Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia
| | - Debbie C Crans
- Department of Chemistry and, The Cell and Molecular Biology Program, Colorado State University, 1301 Center Ave Chemistry B101 Campus Delivery 1872, Fort Collins, CO 80523-1872, USA
| |
Collapse
|
2
|
Levina A, Uslan C, Murakami H, Crans DC, Lay PA. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes. Inorg Chem 2023; 62:17804-17817. [PMID: 37858311 DOI: 10.1021/acs.inorgchem.3c02561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2023]
Abstract
Limited stability of most transition-metal complexes in biological media has hampered their medicinal applications but also created a potential for novel cancer treatments, such as intratumoral injections of cytotoxic but short-lived anticancer drugs. Two related V(V) complexes, [VO(Hshed)(dtb)] (1) and [VO(Hshed)(cat)] (2), where H2shed = N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine, H2dtb = 3,5-di-tert-butylcatechol, and H2cat = 1,2-catechol, decomposed within minutes in cell culture medium at 310 K (t1/2 = 43 and 9 s for 1 and 2, respectively). Despite this, both complexes showed high antiproliferative activities in triple-negative human breast cancer (MDA-MB-231) cells, but the mechanisms of their activities were radically different. Complex 1 formed noncovalent adducts with human serum albumin, rapidly entered cells via passive diffusion, and was nearly as active in a short-term treatment (IC50 = 1.9 ± 0.2 μM at 30 min) compared with a long-term treatment (IC50 = 1.3 ± 0.2 μM at 72 h). The activity of 1 decreased about 20-fold after its decomposition in cell culture medium for 30 min at 310 K. Complex 2 showed similar activities (IC50 ≈ 12 μM at 72 h) in both fresh and decomposed solutions and was inactive in a short-term treatment. The activity of 2 was mainly due to the reactions among V(V) decomposition products, free catechol, and O2 in cell culture medium. As a result, the activity of 1 was less sensitive than that of 2 to the effects of hypoxic conditions that are characteristic of solid tumors and to the presence of apo-transferrin that acts as a scavenger of V(V/IV) decomposition products in blood serum. In summary, complex 1, but not 2, is a suitable candidate for further development as an anticancer drug delivered via intratumoral injections. These results demonstrate the importance of fine-tuning the ligand properties for the optimization of biological activities of metal complexes.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Canan Uslan
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Heide Murakami
- Department of Chemistry and the Cell and Molecular Biology Program, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Debbie C Crans
- Department of Chemistry and the Cell and Molecular Biology Program, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
3
|
Barbosa MDM, de Lima LMA, Alves WADS, de Lima EKB, da Silva LA, da Silva TD, Postal K, Ramadan M, Kostenkova K, Gomes DA, Nunes GG, Pereira MC, da Silva WE, Belian MF, Crans DC, Lira EC. In Vitro, Oral Acute, and Repeated 28-Day Oral Dose Toxicity of a Mixed-Valence Polyoxovanadate Cluster. Pharmaceuticals (Basel) 2023; 16:1232. [PMID: 37765040 PMCID: PMC10536805 DOI: 10.3390/ph16091232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 07/21/2023] [Accepted: 08/13/2023] [Indexed: 09/29/2023] Open
Abstract
Polyoxovanadates (POV) are a subgroup of polyoxometalates (POM), which are nanosized clusters with reported biological activities. This manuscript describes the first toxicity evaluation of a mixed-valence polyoxovanadate, pentadecavanadate, (Me4N)6[V15O36Cl], abbreviated as V15. Cytotoxicity experiments using peripheral blood mononuclear cells (PBMC), larvae of Artemia salina Leach, and in vivo oral acute and repeated 28-day doses in mice was carried out. The LC50 values in PBMC cells and A. salina were 17.5 ± 5.8 μmol L-1, and 17.9 µg L-1, respectively, which indicates high cytotoxic activity. The toxicity in mice was not observed upon acute exposure in a single dose, however, the V15 repeated 28-day oral administration demonstrated high toxicity using 25 mg/kg, 50 mg/kg and, 300 mg/kg doses. The biochemical and hematological analyses during the 28-day administration of V15 showed significant alteration of the metabolic parameters related to the kidney and liver, suggesting moderate toxicity. The V15 toxicity was attributed to the oxidative stress and lipid peroxidation, once thiobarbituric acid (TBAR) levels significantly increased in both males and females treated with high doses of the POV and also in males treated with a lower dose of the POV. This is the first study reporting a treatment-related mortality in animals acutely administrated with a mixed-valence POV, contrasting with the well-known, less toxic decavanadate. These results document the toxicity of this mixed-valence POV, which may not be suitable for biomedical applications.
Collapse
Affiliation(s)
- Mariana de M. Barbosa
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Lidiane M. A. de Lima
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Widarlane A. da S. Alves
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Eucilene K. B. de Lima
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Luzia A. da Silva
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Thiago D. da Silva
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Kahoana Postal
- Centro Politécnico, Departamento de Química, Universidade Federal do Paraná, Curitiba 81530-900, PR, Brazil; (K.P.); (G.G.N.)
| | - Mohammad Ramadan
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
| | - Kateryna Kostenkova
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
| | - Dayane A. Gomes
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Giovana G. Nunes
- Centro Politécnico, Departamento de Química, Universidade Federal do Paraná, Curitiba 81530-900, PR, Brazil; (K.P.); (G.G.N.)
| | - Michelly C. Pereira
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Wagner E. da Silva
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Mônica F. Belian
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Debbie C. Crans
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
- Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523, USA
| | - Eduardo C. Lira
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| |
Collapse
|
4
|
Rehder D. Vanadium in biological systems and medicinal applications. Inorganica Chim Acta 2023. [DOI: 10.1016/j.ica.2023.121387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5
|
Murakami HA, Uslan C, Haase AA, Koehn JT, Vieira AP, Gaebler DJ, Hagan J, Beuning CN, Proschogo N, Levina A, Lay PA, Crans DC. Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have Anticancer Activities. Inorg Chem 2022; 61:20757-20773. [PMID: 36519680 DOI: 10.1021/acs.inorgchem.2c02557] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
A hydrophobic Schiff base catecholate vanadium complex was recently discovered to have anticancer properties superior to cisplatin and suited for intratumoral administration. This [VO(HSHED)(DTB)] complex, where HSHED is N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine and the non-innocent catecholato ligand is di-t-butylcatecholato (DTB), has higher stability compared to simpler catecholato complexes. Three new chloro-substituted Schiff base complexes of vanadium(V) with substituted catecholates as co-ligands were synthesized for comparison with their non-chlorinated Schiff base vanadium complexes, and their properties were characterized. Up to four geometric isomers for each complex were identified in organic solvents using 51V and 1H NMR spectroscopies. Spectroscopy was used to characterize the structure of the major isomer in solution and to demonstrate that the observed isomers are exchanged in solution. All three chloro-substituted Schiff base vanadium(V) complexes with substituted catecholates were also characterized by UV-vis spectroscopy, mass spectrometry, and electrochemistry. Upon testing in human glioblastoma multiforme (T98g) cells as an in vitro model of brain gliomas, the most sterically hindered, hydrophobic, and stable compound [t1/2 (298 K) = 15 min in cell medium] was better than the two other complexes (IC50 = 4.1 ± 0.5 μM DTB, 34 ± 7 μM 3-MeCat, and 19 ± 2 μM Cat). Furthermore, upon aging, the complexes formed less toxic decomposition products (IC50 = 9 ± 1 μM DTB, 18 ± 3 μM 3-MeCat, and 8.1 ± 0.6 μM Cat). The vanadium complexes with the chloro-substituted Schiff base were more hydrophobic, more hydrolytically stable, more easily reduced compared to their corresponding parent counterparts, and the most sterically hindered complex of this series is only the second non-innocent vanadium Schiff base complex with a potent in vitro anticancer activity that is an order of magnitude more potent than cisplatin under the same conditions.
Collapse
Affiliation(s)
- Heide A Murakami
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Canan Uslan
- School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia
| | - Allison A Haase
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Jordan T Koehn
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Adriana Pires Vieira
- School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia
| | - D Jackson Gaebler
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - John Hagan
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Cheryle N Beuning
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States
| | - Nicholas Proschogo
- School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia
| | - Aviva Levina
- School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia.,Sydney Analytical, The University of Sydney, Sydney 2006, New South Wales, Australia
| | - Debbie C Crans
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, United States.,Cell and Molecular Biology Program, Colorado State University, Fort Collins, Colorado 80523, United States
| |
Collapse
|
6
|
Do bioactive 8-hydroxyquinolines oxidovanadium(IV) and (V) complexes inhibit the growth of M. smegmatis? J Inorg Biochem 2022; 237:111984. [PMID: 36152468 DOI: 10.1016/j.jinorgbio.2022.111984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Revised: 08/22/2022] [Accepted: 08/25/2022] [Indexed: 01/18/2023]
Abstract
The antiproliferative effects of four series of VIVO- and VVO-based compounds containing 8-hydroxyquinoline ligands on the bacterium Mycolicibacterium smegmatis (M. smeg) were investigated. The effects on M. smeg were compared to the antiproliferative effects on the protozoan parasite Trypanosoma cruzi (T. cruzi), the causative agent for Chagas disease. In this study, we investigate the speciation of these compounds under physiological conditions as well as the antiproliferative effects on the bacterium M. smeg. We find that the complexes are more stable the less H2O is present, and that the stability increases in lipid-like environments. Only one heteroleptic complex and two homoleptic complexes were found to show similar antiproliferative effects on M. smeg as reported for T. cruzi so the responses generally observed by M.smeg. is less than observed by the pathogen. In summary, we find that M. smeg is more sensitive to the detailed structure of the V-complex but overall these complexes are less effective against M. smeg compared to T. cruzi.
Collapse
|
7
|
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections. Pharmaceutics 2022; 14:pharmaceutics14040790. [PMID: 35456624 PMCID: PMC9026487 DOI: 10.3390/pharmaceutics14040790] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 03/24/2022] [Accepted: 03/29/2022] [Indexed: 11/30/2022] Open
Abstract
Injections of highly cytotoxic or immunomodulating drugs directly into the inoperable tumor is a procedure that is increasingly applied in the clinic and uses established Pt-based drugs. It is advantageous for less stable anticancer metal complexes that fail administration by the standard intravenous route. Such hydrophobic metal-containing complexes are rapidly taken up into cancer cells and cause cell death, while the release of their relatively non-toxic decomposition products into the blood has low systemic toxicity and, in some cases, may even be beneficial. This concept was recently proposed for V(V) complexes with hydrophobic organic ligands, but it can potentially be applied to other metal complexes, such as Ti(IV), Ga(III) and Ru(III) complexes, some of which were previously unsuccessful in human clinical trials when administered via intravenous injections. The potential beneficial effects include antidiabetic, neuroprotective and tissue-regenerating activities for V(V/IV); antimicrobial activities for Ga(III); and antimetastatic and potentially immunogenic activities for Ru(III). Utilizing organic ligands with limited stability under biological conditions, such as Schiff bases, further enhances the tuning of the reactivities of the metal complexes under the conditions of intratumoral injections. However, nanocarrier formulations are likely to be required for the delivery of unstable metal complexes into the tumor.
Collapse
|